Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Centessa Pharmaceuticals Q2 EPS $(0.65)

Centessa Pharmaceuticals (NASDAQ:CNTA) reported quarterly losses of $(0.65) per share.

byLuke J Jacobi

August 16, 2021

1 minute read

Centessa Pharmaceuticals (NASDAQ:CNTA) reported quarterly losses of $(0.65) per share.

Credit Suisse Maintains Outperform on Bill.com Holdings, Lowers Price Target to $160

By Benzinga Newsdesk

Today, 6:14 PM

Credit Suisse analyst Nik Cremo maintains Bill.com Holdings (NYSE:BILL) with a Outperform and lowers the price target from $200 to $160.

BILL

Stronghold Digital Mining Q3 Sales $6.00M Beat $4.67M Estimate

By Benzinga Newsdesk

Today, 6:14 PM

Stronghold Digital Mining (NASDAQ:SDIG) reported quarterly sales of $6.00 million which beat the analyst consensus estimate of $4.67 million by 28.48 percent.

SDIG

Wedbush Bumps Up Cavco Industries Price Target By ~24%

By Shivani Kumaresan

Today, 6:14 PM

Wedbush analyst Jay McCanless raised the price target on Cavco Industries Inc (NASDAQ:CVCO) to $315 from $255 and kept a Neutral rating on…

CVCO

JMP Securities Downgrades Intellia Therapeutics to Market Perform

By Benzinga Newsdesk

Today, 6:14 PM

JMP Securities analyst Silvan Tuerkcan downgrades Intellia Therapeutics (NASDAQ:NTLA) from Market Outperform to Market Perform.

NTLA

Centessa Pharmaceuticals Q2 EPS $(0.65)

Related Posts

Credit Suisse Maintains Outperform on Bill.com Holdings, Lowers Price Target to $160

Stronghold Digital Mining Q3 Sales $6.00M Beat $4.67M Estimate

Wedbush Bumps Up Cavco Industries Price Target By ~24%

JMP Securities Downgrades Intellia Therapeutics to Market Perform